Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells
出版年份 2021 全文链接
标题
Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells
作者
关键词
Non-small cell lung cancer, GPX4, mTOR, Lapatinib, Ferroptosis
出版物
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 567, Issue -, Pages 154-160
出版商
Elsevier BV
发表日期
2021-06-20
DOI
10.1016/j.bbrc.2021.06.051
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation
- (2021) Yilei Zhang et al. Nature Communications
- Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer
- (2020) Sanne C. F. A. Huijberts et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo
- (2020) Shunnan Yao et al. CANCER LETTERS
- Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
- (2020) Bowen Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Neuroprotective Effects of the Anti-cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis
- (2020) Ji-Ning Jia et al. Frontiers in Pharmacology
- Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
- (2020) Xiang Song et al. Frontiers in Oncology
- Overcoming TKI resistance in fusion-driven NSCLC: new generation inhibitors and rationale for combination strategies
- (2020) Alessandro Russo et al. Translational Lung Cancer Research
- Sigma‐1 receptor protects against ferroptosis in hepatocellular carcinoma cells
- (2019) Tao Bai et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin
- (2019) Xuefei Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
- (2019) Gloria E. Villalpando-Rodriguez et al. Oxidative Medicine and Cellular Longevity
- Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
- (2019) Ana C.Z. Gelatti et al. LUNG CANCER
- Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
- (2018) J Remon et al. ANNALS OF ONCOLOGY
- Role of GPX4 in ferroptosis and its pharmacological implication
- (2018) Tobias M. Seibt et al. FREE RADICAL BIOLOGY AND MEDICINE
- Anti-tumor effects of Atractylenolide I on bladder cancer cells
- (2016) Rui Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Translational Regulation of GPx-1 and GPx-4 by the mTOR Pathway
- (2014) Emily N. Reinke et al. PLoS One
- Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
- (2012) Sylvia S. Gayle et al. Anti-Cancer Agents in Medicinal Chemistry
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started